These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 16686719

  • 1. The beneficial effect of alfuzosin 10 mg once daily in 'real-life' practice on lower urinary tract symptoms (LUTS), quality of life and sexual dysfunction in men with LUTS and painful ejaculation.
    Nickel JC, Elhilali M, Emberton M, Vallancien G, Alf-One Study Group.
    BJU Int; 2006 Jun; 97(6):1242-6. PubMed ID: 16686719
    [Abstract] [Full Text] [Related]

  • 2. Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction.
    van Moorselaar RJ, Hartung R, Emberton M, Harving N, Matzkin H, Elhilali M, Alcaraz A, Vallancien G, ALF-ONE Study Group.
    BJU Int; 2005 Mar; 95(4):603-8. PubMed ID: 15705088
    [Abstract] [Full Text] [Related]

  • 3. Long-term efficacy and safety of alfuzosin 10 mg once daily: a 2-year experience in 'real-life' practice.
    Elhilali M, Emberton M, Matzkin H, van Moorselaar RJ, Hartung R, Harving N, Alcaraz A, Vallancien G, ALF-ONE Study Group.
    BJU Int; 2006 Mar; 97(3):513-9. PubMed ID: 16469018
    [Abstract] [Full Text] [Related]

  • 4. Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.
    Vallancien G, Emberton M, Alcaraz A, Matzkin H, van Moorselaar RJ, Hartung R, Harving N, Elhilali M, ALF-ONE Study Group.
    BJU Int; 2008 Apr; 101(7):847-52. PubMed ID: 18321317
    [Abstract] [Full Text] [Related]

  • 5. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
    Nickel JC, Elhilali M, Vallancien G, ALF-ONE Study Group.
    BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
    [Abstract] [Full Text] [Related]

  • 6. Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Rosen RC, Fitzpatrick JM, ALF-LIFE Study Group.
    BJU Int; 2009 Oct; 104(7):974-83. PubMed ID: 19426189
    [Abstract] [Full Text] [Related]

  • 7. Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function.
    Lowe FC.
    BJU Int; 2005 Jun; 95 Suppl 4():12-8. PubMed ID: 15871731
    [Abstract] [Full Text] [Related]

  • 8. Effects of alfuzosin 10 mg once daily on sexual function in men treated for symptomatic benign prostatic hyperplasia.
    Rosen R, Seftel A, Roehrborn CG.
    Int J Impot Res; 2007 Jun; 19(5):480-5. PubMed ID: 17717526
    [Abstract] [Full Text] [Related]

  • 9. Symptom deterioration during treatment and history of AUR are the strongest predictors for AUR and BPH-related surgery in men with LUTS treated with alfuzosin 10 mg once daily.
    Emberton M, Elhilali M, Matzkin H, Harving N, van Moorselaar J, Hartung R, Alcaraz A, Vallancien G, Alf-One Study Group.
    Urology; 2005 Aug; 66(2):316-22. PubMed ID: 16098361
    [Abstract] [Full Text] [Related]

  • 10. Safety and efficacy of a prolonged-release formulation of alfuzosin 10 mg once daily in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Kongkanand A, Chodchoy V, Lojanapiwat B, Pumpaisanchai S, Ratana-Olarn K, Sae-Tang P, Taweemonkongsap T.
    J Med Assoc Thai; 2009 Jul; 92(7):969-78. PubMed ID: 19626818
    [Abstract] [Full Text] [Related]

  • 11. Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study.
    Roehrborn CG.
    BJU Int; 2006 Apr; 97(4):734-41. PubMed ID: 16536764
    [Abstract] [Full Text] [Related]

  • 12. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
    Emberton M, Lukacs B, Matzkin H, Alcaraz A, Elhilali M, Vallancien G.
    J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
    [Abstract] [Full Text] [Related]

  • 13. [Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging.male (MSAM-7)].
    Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, O'Leary MP, Puppo P, Chris R, Giuliano F.
    Prog Urol; 2004 Jun; 14(3):332-44. PubMed ID: 15373175
    [Abstract] [Full Text] [Related]

  • 14. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK, Garcia L, Patron N, Moh LC, Sundram M, Leungwattanakij S, Pripatnanont C, Cheng C, Chi-Wai M, Loi-Cheong N.
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [Abstract] [Full Text] [Related]

  • 15. Comparative efficacy of two alpha-adrenoreceptor antagonists, doxazosin and alfuzosin, in patients with lower urinary tract symptoms from benign prostatic enlargement.
    de Reijke TM, Klarskov P.
    BJU Int; 2004 Apr; 93(6):757-62. PubMed ID: 15049986
    [Abstract] [Full Text] [Related]

  • 16. Impact of alfuzosin on sexual function in Taiwanese men with benign prostatic hyperplasia.
    Hwang TI, Chu SH, Lin MS, Chen CS, Lee LM, Chang HC, Yeh SD, Chen WH, Chiang PH.
    Kaohsiung J Med Sci; 2012 Aug; 28(8):429-34. PubMed ID: 22892164
    [Abstract] [Full Text] [Related]

  • 17. Impact of medical treatments for benign prostatic hyperplasia on sexual function.
    Giuliano F.
    BJU Int; 2006 Apr; 97 Suppl 2():34-8; discussion 44-5. PubMed ID: 16507052
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of two doses (10 and 15 mg) of alfuzosin or tamsulosin (0.4 mg) once daily for treating symptomatic benign prostatic hyperplasia.
    Nordling J.
    BJU Int; 2005 May; 95(7):1006-12. PubMed ID: 15839922
    [Abstract] [Full Text] [Related]

  • 19. Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.
    Kaplan SA, Gonzalez RR, Te AE.
    Eur Urol; 2007 Jun; 51(6):1717-23. PubMed ID: 17258855
    [Abstract] [Full Text] [Related]

  • 20. Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms.
    Vallancien G, Emberton M, Harving N, van Moorselaar RJ, Alf-One Study Group.
    J Urol; 2003 Jun; 169(6):2257-61. PubMed ID: 12771764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.